Multifunctional biomimetic nanocarriers for the treatment of atherosclerosis
Atherosclerosis (AS) has been considered a systemic disease characterized by the excessive generation of reactive oxygen species (ROS) and the
Category: CD derivatives
Cyclodextrin-based carriers for targeted drug delivery, a new review
This post was written by Ibrahim Hussein. Cyclodextrin-based carriers have evolved beyond their traditional role as solubilizing agents toward ligand-targeted,
Selective removal of 7-ketocholesterol by a CD-dimer, a novel atherosclerosis therapeutic candidate
The removal of the toxic oxidized cholesterol, 7-ketocholesterol (7KC), from cells through the administration of therapeutics has the potential to
Dual activity of low-molecular-weight polymeric β-cyclodextrins against tuberculosis
/The biological properties of pβCD of different molecular weights were studied. Strikingly, only the low-molecular-weight pβCD (LMW-pβCD) displayed antibacterial activity,
Novel delivery systems for Resveratrol
A novel polymer, β-cyclodextrin-epichlorohydrin-cyanoguanidine polymer (CDPC) was synthesized to evaluate its potential as an efficient carrier for the encapsulation of
First EMA regulation on the residues of betadex sulfobutylether sodium in foodstuffs of animal
Regulation (European Commission) No. 470/2009 lays down Community procedures for the establishment of residue limits of pharmaceutical active substances, excipients
From an Idea to a Journey: My Path Toward Treating Gout and Hyperuricemia With Cyclodextrins
When I look back at the last few years, it’s hard not to feel moved by what this project has
A β-cyclodextrin polymer reduces cholesterol accumulation and mitigates autophagy dysfunction in vitro and in a Niemann–Pick Type C animal model
Niemann–Pick disease type C (NPC) and Alzheimer’s disease (AD) are both characterised by cognitive decline and neurological impairment. In each
Methyl BCD-based supramolecular polyrotaxane as theranostic in anticancer immunotherapy
Despite the tremendous therapeutic promise of activating stimulators of interferon genes (STING) enable to prime robust de novo T-cell responses,
β–Cyclodextrin polymerization for selective separation of long-chain per- and poly-fluorinated alkyl substances at environmentally relevant concentrations
Per- and polyfluorinated alkyl substances (PFASs), especially long-chain compounds such as perfluorooctanoic acid (PFOA), perfluorooctanesulfonic acid (PFOS), perfluorononanoic acid (PFNA),